Request Appointment
1400 S Orange AveOrlando, FL 32806
Overview of Dr. Thomas
Dr. Sajeve Thomas is an oncologist in Orlando, FL and is affiliated with Orlando Health Orlando Regional Medical Center. He received his medical degree from University of Florida College of Medicine and has been in practice 12 years. He is one of 66 doctors at Orlando Health Orlando Regional Medical Center who specialize in Oncology.
Education & Training
University of FloridaFellowship, Hematology and Medical Oncology, 2008 - 2011
University of South Florida MorsaniResidency, Internal Medicine, 2005 - 2008- University of Florida College of MedicineClass of 2005
Certifications & Licensure
FL State Medical License 2007 - 2026
MT State Medical License 2024 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer Start of enrollment: 2011 Apr 01
- Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer Start of enrollment: 2012 Dec 17
- FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer Start of enrollment: 2013 May 01
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsPhase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma.Omid Hamid, Karl D Lewis, Amy Weise, Meredith McKean, Kyriakos P Papadopoulos
Journal of Clinical Oncology. 2024-08-20 - 120 citationsIndividualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.Jeffrey S Weber, Matteo S Carlino, Adnan Khattak, Tarek Meniawy, George Ansstas
Lancet. 2024-02-17 - 109 citationsEfficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immu...Jason Chesney, Karl D Lewis, Harriet Kluger, Omid Hamid, Eric Whitman
Journal for Immunotherapy of Cancer. 2022-12-01
Press Mentions
Cancer Specialists in Florida See Dramatic Results with New Clinical TrialNovember 22nd, 2021
Iovance: Assessing the Potential for Further UpsideMay 20th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
